|
|
|
| home > news > detailed info |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
CytoSMART Technologies Introduces Machine-Learning Algorithm for Organoid Analysis on the CytoSMART Omni Systems |
 |
|
9 June 2022, Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies, an Axion Bio company, today announced the launch of a new Organoid Analysis Module for use with its flagship CytoSMART Omni live-cell imaging product line. The innovative software module, which incorporates next-generation machine learning capabilities, is designed to meet growing scientific demand from researchers and drug developers using complex three-dimensional (3D) in vitro models such as organoids, spheroids, and tumoroids to study disease mechanisms and identify therapeutic targets in the fields of neurology, gastroenterology, oncology and more.
According to Joffry Maltha, CEO of CytoSMART Technologies, the Organoid Analysis Module reflects the company’s commitment to provide customers with cutting-edge tools to accelerate scientific discovery. "The use of organoids in research is allowing scientists to understand a variety of diseases in novel ways and pursue therapeutic strategies more quickly than ever before. While imaging is a cornerstone of many experiments, analysis is often a hurdle. Our new software promises to provide fast, accurate results and give organoid researchers access to the Omni’s automated whole-well imaging capabilities. We look forward to seeing the discoveries it enables as the field continues its rapid advances."
Organoids are at the forefront of discovery and represent a bridge between two-dimensional cell cultures and more complex animal models. Often generated from stem cells, organoids have transformed research by allowing scientists to create miniaturized versions of organs in the laboratory that mimic many of the biological processes observed in humans. Normal biological processes remain undisturbed inside an incubator during experiments with the Omni’s label-free, whole-well brightfield imaging, making the technology especially valuable for scientists studying long-term therapeutic effects, disease progression, or developmental biology.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Meeting increasing demand for storing injectable drugs – SCHOTT plans to triple ready-to-use vial production capacity in the U.S.
As a globally trusted partner for advanced drug containment and delivery
solutions, SCHOTT is announcing plans to triple its vial production
capacity at its site in Lebanon, PA. In doing so, the international
technology company will further strengthen its business for ready-to-use
(RTU) solutions, which have emerged as an often preferred drug
containment alternative for high-value medications. “With our
investment, we are underlining our commitment to the global pharma
industry and particularly the U.S. market. Additionally, we are
enhancing our regional manufacturing footprint in Lebanon, Pennsylvania,
where we are proudly celebrating our site’s 30th anniversary,” said
Andreas Reisse, Executive Vice President of SCHOTT Pharma.
More info >> |
|
 |
White Papers |
 |
|
Challenges of Analytical Method Transfer in the Pharmaceutical Industry
RSSL
The development and validation of suitable analytical methods is a critical part of the overall drug-development life-cycle. For the majority of products, particularly those that are clinically successful, the transfer of the analytical method between laboratories will be required. This process is designed to verify that a given laboratory is capable of performing a test method for its intended purpose. This can be performed either internally (at the same company), or, with the on-going increasing trend in outsourcing, to an external Contract Research or Development organisation (CRO or CDO).
More info >> |
|
 |
Industry Events |
 |
Connect in Pharma
14-15 September 2022, Plaexpo, Geneva, Switzerland
The new event driving innovation for pharma and biopharma businesses,
Connect in Pharma will unite key players in Pharmaceutical and
Biopharmaceutical packaging and production in Geneva on 14 – 15
September 2022.
More info >> |
|
|
